Literature DB >> 16624867

Muc4-ErbB2 complex formation and signaling in polarized CACO-2 epithelial cells indicate that Muc4 acts as an unorthodox ligand for ErbB2.

Victoria P Ramsauer1, Vanessa Pino, Amjad Farooq, Coralie A Carothers Carraway, Pedro J I Salas, Kermit L Carraway.   

Abstract

Muc4 serves as an intramembrane ligand for the receptor tyrosine kinase ErbB2. The time to complex formation and the stoichiometry of the complex were determined to be <15 min and 1:1 by analyses of Muc4 and ErbB2 coexpressed in insect cells and A375 tumor cells. In polarized CACO-2 cells, Muc4 expression causes relocalization of ErbB2, but not its heterodimerization partner ErbB3, to the apical cell surface, effectively segregating the two receptors. The apically located ErbB2 is phosphorylated on tyrosines 1139 and 1248. The phosphorylated ErbB2 in CACO-2 cells recruits the cytoplasmic adaptor protein Grb2, consistent with previous studies showing phosphotyrosine 1139 to be a Grb2 binding site. To address the issue of downstream signaling from apical ErbB2, we analyzed the three MAPK pathways of mammalian cells, Erk, p38, and JNK. Consistent with the more differentiated phenotype of the CACO-2 cells, p38 phosphorylation was robustly increased by Muc4 expression, with a consequent activation of Akt. In contrast, Erk and JNK phosphorylation was not changed. The ability of Muc4 to segregate ErbB2 and other ErbB receptors and to alter downstream signaling cascades in polarized epithelial cells suggests that it has a role in regulating ErbB2 in differentiated epithelia.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16624867      PMCID: PMC1483030          DOI: 10.1091/mbc.e05-09-0895

Source DB:  PubMed          Journal:  Mol Biol Cell        ISSN: 1059-1524            Impact factor:   4.138


  64 in total

1.  Muc4/sialomucin complex, the intramembrane ErbB2 ligand, induces specific phosphorylation of ErbB2 and enhances expression of p27(kip), but does not activate mitogen-activated kinase or protein kinaseB/Akt pathways.

Authors:  Scott Jepson; Masanobu Komatsu; Bushra Haq; Maria E Arango; Daming Huang; Coralie A Carothers Carraway; Kermit L Carraway
Journal:  Oncogene       Date:  2002-10-24       Impact factor: 9.867

2.  Muc4/sialomucin complex, the intramembrane ErbB2 ligand, translocates ErbB2 to the apical surface in polarized epithelial cells.

Authors:  Victoria P Ramsauer; Coralie A Carothers Carraway; Pedro J I Salas; Kermit L Carraway
Journal:  J Biol Chem       Date:  2003-05-14       Impact factor: 5.157

3.  Evolutionary analysis of the ErbB receptor and ligand families.

Authors:  R A Stein; J V Staros
Journal:  J Mol Evol       Date:  2000-05       Impact factor: 2.395

Review 4.  Biochemical and clinical implications of the ErbB/HER signaling network of growth factor receptors.

Authors:  L N Klapper; M H Kirschbaum; M Sela; Y Yarden
Journal:  Adv Cancer Res       Date:  2000       Impact factor: 6.242

5.  The crystal structure of a truncated ErbB2 ectodomain reveals an active conformation, poised to interact with other ErbB receptors.

Authors:  Thomas P J Garrett; Neil M McKern; Meizhen Lou; Thomas C Elleman; Timothy E Adams; George O Lovrecz; Michael Kofler; Robert N Jorissen; Edouard C Nice; Antony W Burgess; Colin W Ward
Journal:  Mol Cell       Date:  2003-02       Impact factor: 17.970

6.  Crystal structure of the complex of human epidermal growth factor and receptor extracellular domains.

Authors:  Hideo Ogiso; Ryuichiro Ishitani; Osamu Nureki; Shuya Fukai; Mari Yamanaka; Jae-Hoon Kim; Kazuki Saito; Ayako Sakamoto; Mio Inoue; Mikako Shirouzu; Shigeyuki Yokoyama
Journal:  Cell       Date:  2002-09-20       Impact factor: 41.582

Review 7.  Signal transduction in mammary tumorigenesis: a transgenic perspective.

Authors:  D L Dankort; W J Muller
Journal:  Oncogene       Date:  2000-02-21       Impact factor: 9.867

8.  Overexpression of sialomucin complex, a rat homologue of MUC4, inhibits tumor killing by lymphokine-activated killer cells.

Authors:  M Komatsu; L Yee; K L Carraway
Journal:  Cancer Res       Date:  1999-05-01       Impact factor: 12.701

9.  Structure of the extracellular region of HER2 alone and in complex with the Herceptin Fab.

Authors:  Hyun-Soo Cho; Karen Mason; Kasra X Ramyar; Ann Marie Stanley; Sandra B Gabelli; Dan W Denney; Daniel J Leahy
Journal:  Nature       Date:  2003-02-13       Impact factor: 49.962

10.  NHE blockade inhibits chemokine production and NF-kappaB activation in immunostimulated endothelial cells.

Authors:  Zoltán H Németh; Edwin A Deitch; Qi Lu; Csaba Szabó; György Haskó
Journal:  Am J Physiol Cell Physiol       Date:  2002-08       Impact factor: 4.249

View more
  31 in total

1.  Novel monoclonal antibodies against the proximal (carboxy-terminal) portions of MUC16.

Authors:  Thapi Dharma Rao; Kay J Park; Peter Smith-Jones; Alexia Iasonos; Irina Linkov; Robert A Soslow; David R Spriggs
Journal:  Appl Immunohistochem Mol Morphol       Date:  2010-10

2.  TGF-β and Smad3 modulate PI3K/Akt signaling pathway in vascular smooth muscle cells.

Authors:  Pasithorn A Suwanabol; Stephen M Seedial; Fan Zhang; Xudong Shi; Yi Si; Bo Liu; K Craig Kent
Journal:  Am J Physiol Heart Circ Physiol       Date:  2012-03-23       Impact factor: 4.733

3.  Soluble neuregulin-1 has bifunctional, concentration-dependent effects on Schwann cell myelination.

Authors:  Neeraja Syed; Kavya Reddy; David P Yang; Carla Taveggia; James L Salzer; Patrice Maurel; Haesun A Kim
Journal:  J Neurosci       Date:  2010-04-28       Impact factor: 6.167

4.  Mechanistic and signaling analysis of Muc4-ErbB2 signaling module: new insights into the mechanism of ligand-independent ErbB2 activity.

Authors:  Goldi A Kozloski; Coralie A Carothers Carraway; Kermit L Carraway
Journal:  J Cell Physiol       Date:  2010-09       Impact factor: 6.384

Review 5.  Cell polarity in motion: redefining mammary tissue organization through EMT and cell polarity transitions.

Authors:  Nathan J Godde; Ryan C Galea; Imogen A Elsum; Patrick O Humbert
Journal:  J Mammary Gland Biol Neoplasia       Date:  2010-05-12       Impact factor: 2.673

Review 6.  Membrane-bound mucins: the mechanistic basis for alterations in the growth and survival of cancer cells.

Authors:  S Bafna; S Kaur; S K Batra
Journal:  Oncogene       Date:  2010-03-29       Impact factor: 9.867

7.  Upregulation of mucin4 in ER-positive/HER2-overexpressing breast cancer xenografts with acquired resistance to endocrine and HER2-targeted therapies.

Authors:  Albert C Chen; Ilenia Migliaccio; Mothaffar Rimawi; Sara Lopez-Tarruella; Chad J Creighton; Suleiman Massarweh; Catherine Huang; Yen-Chao Wang; Surinder K Batra; M Carolina Gutierrez; C Kent Osborne; Rachel Schiff
Journal:  Breast Cancer Res Treat       Date:  2012-05-29       Impact factor: 4.872

Review 8.  Structure, evolution, and biology of the MUC4 mucin.

Authors:  Pallavi Chaturvedi; Ajay P Singh; Surinder K Batra
Journal:  FASEB J       Date:  2007-11-16       Impact factor: 5.191

Review 9.  Muc4/MUC4 functions and regulation in cancer.

Authors:  Kermit L Carraway; George Theodoropoulos; Goldi A Kozloski; Coralie A Carothers Carraway
Journal:  Future Oncol       Date:  2009-12       Impact factor: 3.404

10.  Regulation of the membrane mucin Muc4 in corneal epithelial cells by proteosomal degradation and TGF-beta.

Authors:  Joseph Lomako; Wieslawa M Lomako; Coralie A Carothers Carraway; Kermit L Carraway
Journal:  J Cell Physiol       Date:  2010-04       Impact factor: 6.384

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.